This is a news story, published by News Center, that relates primarily to Roger Stupp news.
For more Roger Stupp news, you can click here:
more Roger Stupp newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from News Center, you can click here:
more news from News CenterOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
recurrent glioblastoma. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest glioblastoma news, patient glioblastoma samples news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
glioblastoma tumor cellsNews Center
•94% Informative
Using a novel drug to target the STING pathway in glioblastoma reprogrammed previously suppressed immune responses, according to recent findings published in the Journal of Clinical Investigation .
The study demonstrates the potential of a novel therapeutic strategy for patients who do not typically respond to current FDA approved immunotherapies.
The scientists are now beginning to evaluate the agonist in mouse models who received radiation to determine if the therapy could be effective.
Co-authors include Roger Stupp , the Paul C. Bucy Professor of Neurological Surgery and chief of Neuro -oncology in the Ken and Ruth Davee Department of Neurology .
Heimberger is also the director of the Lou and Jean Malnati Brain Tumor Institute at the Lurie Cancer Center .
VR Score
95
Informative language
96
Neutral language
73
Article tone
formal
Language
English
Language complexity
90
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
19
Source diversity
6
Affiliate links
no affiliate links